68 related articles for article (PubMed ID: 9021169)
1. The biotransformation of isoprene and the two isoprene monoepoxides by human cytochrome P450 enzymes, compared to mouse and rat liver microsomes.
Bogaards JJ; Venekamp JC; van Bladeren PJ
Chem Biol Interact; 1996 Dec; 102(3):169-82. PubMed ID: 9021169
[TBL] [Abstract][Full Text] [Related]
2. Differences in butadiene adduct formation between rats and mice not due to selective inhibition of CYP2E1 by butadiene metabolites.
Pianalto KM; Hartman JH; Boysen G; Miller GP
Toxicol Lett; 2013 Nov; 223(2):221-7. PubMed ID: 24021170
[TBL] [Abstract][Full Text] [Related]
3. Trapping of cis-2-butene-1,4-dial to measure furan metabolism in human liver microsomes by cytochrome P450 enzymes.
Gates LA; Lu D; Peterson LA
Drug Metab Dispos; 2012 Mar; 40(3):596-601. PubMed ID: 22187484
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of 2'-deoxyadenosine adducts formed by isoprene monoepoxides in vitro.
Begemann P; Boysen G; Georgieva NI; Sangaiah R; Koshlap KM; Koc H; Zhang D; Golding BT; Gold A; Swenberg JA
Chem Res Toxicol; 2011 Jul; 24(7):1048-61. PubMed ID: 21548641
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide N-oxidation by CYP2E1 in human liver microsomes.
Real AM; Hong S; Pissios P
Drug Metab Dispos; 2013 Mar; 41(3):550-3. PubMed ID: 23418369
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of ethylene and ethylene oxide in subcellular fractions of lungs and livers of male B6C3F1 mice and male fischer 344 rats and of human livers.
Li Q; Csanády GA; Kessler W; Klein D; Pankratz H; Pütz C; Richter N; Filser JG
Toxicol Sci; 2011 Oct; 123(2):384-98. PubMed ID: 21785163
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial P450-dependent arachidonic acid metabolism by TCDD-induced hepatic CYP1A5; conversion of EETs to DHETs by mitochondrial soluble epoxide hydrolase.
Labitzke EM; Diani-Moore S; Rifkind AB
Arch Biochem Biophys; 2007 Dec; 468(1):70-81. PubMed ID: 17959137
[TBL] [Abstract][Full Text] [Related]
8. In Vitro Metabolism of Oprozomib, an Oral Proteasome Inhibitor: Role of Epoxide Hydrolases and Cytochrome P450s.
Wang Z; Fang Y; Teague J; Wong H; Morisseau C; Hammock BD; Rock DA; Wang Z
Drug Metab Dispos; 2017 Jul; 45(7):712-720. PubMed ID: 28428366
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of soluble epoxide hydrolase by natural isothiocyanates.
Elbarbry F; Espiritu MJ; Soo K; Yee B; Taylor J
Biochem Biophys Res Commun; 2024 Jun; 725():150261. PubMed ID: 38897040
[TBL] [Abstract][Full Text] [Related]
10. Conversion of 7-dehydrocholesterol to 7-ketocholesterol is catalyzed by human cytochrome P450 7A1 and occurs by direct oxidation without an epoxide intermediate.
Shinkyo R; Xu L; Tallman KA; Cheng Q; Porter NA; Guengerich FP
J Biol Chem; 2011 Sep; 286(38):33021-8. PubMed ID: 21813643
[TBL] [Abstract][Full Text] [Related]
11. Preclinical metabolism of LB42908, a novel farnesyl transferase inhibitor, and its effects on the cytochrome P450 isozyme activities.
Kim HJ; Lee SH; Koh JS; Lee SH
Bioorg Med Chem Lett; 2012 May; 22(9):3067-71. PubMed ID: 22497764
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo metabolic activation and hepatotoxicity of chlorzoxazone mediated by CYP3A.
Sun C; Zhang M; Guan C; Li W; Peng Y; Zheng J
Arch Toxicol; 2024 Apr; 98(4):1095-1110. PubMed ID: 38369618
[TBL] [Abstract][Full Text] [Related]
13. Identification of an Epoxide Metabolite of Amitriptyline
Li X; Xin L; Yang L; Yang Y; Li W; Zhang M; Liao Y; Sun C; Li W; Peng Y; Zheng J
Chem Res Toxicol; 2024 Jun; 37(6):935-943. PubMed ID: 38761382
[TBL] [Abstract][Full Text] [Related]
14. Specific packaging and circulation of cytochromes P450, especially 2E1 isozyme, in human plasma exosomes and their implications in cellular communications.
Kumar S; Sinha N; Gerth KA; Rahman MA; Yallapu MM; Midde NM
Biochem Biophys Res Commun; 2017 Sep; 491(3):675-680. PubMed ID: 28756226
[TBL] [Abstract][Full Text] [Related]
15. CYP2E1 metabolism of styrene involves allostery.
Hartman JH; Boysen G; Miller GP
Drug Metab Dispos; 2012 Oct; 40(10):1976-83. PubMed ID: 22807108
[TBL] [Abstract][Full Text] [Related]
16. Molecular probes of the mechanism of cytochrome P450. Oxygen traps a substrate radical intermediate.
Cooper HL; Groves JT
Arch Biochem Biophys; 2011 Mar; 507(1):111-8. PubMed ID: 21075070
[TBL] [Abstract][Full Text] [Related]
17. Cross-species variability in lobular geometry and cytochrome P450 hepatic zonation: insights into CYP1A2, CYP2D6, CYP2E1 and CYP3A4.
Albadry M; Küttner J; Grzegorzewski J; Dirsch O; Kindler E; Klopfleisch R; Liska V; Moulisova V; Nickel S; Palek R; Rosendorf J; Saalfeld S; Settmacher U; Tautenhahn HM; König M; Dahmen U
Front Pharmacol; 2024; 15():1404938. PubMed ID: 38818378
[TBL] [Abstract][Full Text] [Related]
18. The roles of carboxylesterase and CYP isozymes on the in vitro metabolism of T-2 toxin.
Lin NN; Chen J; Xu B; Wei X; Guo L; Xie JW
Mil Med Res; 2015; 2():13. PubMed ID: 26140218
[TBL] [Abstract][Full Text] [Related]
19. Synergistic metabolic toxicity screening using microsome/DNA electrochemiluminescent arrays and nanoreactors.
Krishnan S; Hvastkovs EG; Bajrami B; Choudhary D; Schenkman JB; Rusling JF
Anal Chem; 2008 Jul; 80(14):5279-85. PubMed ID: 18563913
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Characterization and Rescue of VX Metabolism in Human Liver Microsomes.
Lane TR; Koebel D; Lucas E; Moyer R; Ekins S
Drug Metab Dispos; 2024 May; 52(6):574-579. PubMed ID: 38594080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
